At Investor Conferences

Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x100px
Organisation › Details

uMotif Ltd.

uMotif's mission is to put patients at the center of clinical research. Designed with patients for patients, the uMotif patient-first eClinical platform powers site-based to fully decentralized clinical, real-world, and post-marketing research. By engaging patients and healthcare professionals, uMotif is trusted by global pharmaceutical companies, biotechs, CROs, and academic institutions to capture large volumes of eCOA/ePRO, symptom, and wearable device data. *

 

Period Start 2012-03-16 established
Products Industry clinical research software
  Industry 2 clinical research
Person Person Rosenberg, Steve (uMotif 202205 CEO)
     
Region Region London, Greater London
  Country United Kingdom (GB)
  Street 30 Stamford Street
WeWork, 3rd Floor
  City SE1 9LQ London
    Address record changed: 2022-05-30
     
Basic data Employees n. a.
     
    * Document for �About Section�: uMotif Ltd.. (5/25/22). "Press Release: uMotif – the Patient-first Data Capture and Decentralized Clinical Trials Platform – Announces $25.5m of New Investment from a Fund Managed by Athyrium Capital Management". London & New York, NY.
     
   
Record changed: 2022-05-30

Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x200px

More documents for uMotif Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group ChinaBio Partnering Forum 2022 650x300




» top